![](/img/cover-not-exists.png)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Domagrozumab (PF-06252616), an Antimyostatin Monoclonal Antibody, in Healthy Subjects
Bhattacharya, Indranil, Pawlak, Sylvester, Marraffino, Shannon, Christensen, Jared, Sherlock, Sarah P., Alvey, Christine, Morris, Carl, Arkin, Steven, Binks, MichaelLanguage:
english
Journal:
Clinical Pharmacology in Drug Development
DOI:
10.1002/cpdd.386
Date:
September, 2017
File:
PDF, 921 KB
english, 2017